Braidwell LP Axonics, Inc. Transaction History

Braidwell LP

  • $3.53 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$48.64 - $62.51 $10.7 Million - $13.7 Million
-219,264 Reduced 38.21%
354,527 $19.9 Billion
Q2 2023

Aug 14, 2023
BUY
$47.99 - $60.21 $19.5 Million - $24.5 Million
407,087 Added 244.2%
573,791 $29 Billion
Q1 2023

May 15, 2023
BUY
$52.6 - $67.34 $8.77 Million - $11.2 Million
166,704 New
166,704 $9.1 Billion

Others Institutions Holding AXNX

# of Institutions
234
Shares Held
42.1M
Call Options Held
83.4K
Put Options Held
65.3K
View Full List

About Axonics, Inc.

AXNX Quotes by TradingView
  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Braidwell LP Portfolio

Follow Braidwell LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

News

Stay updated on Braidwell LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email